Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

Delayed Data
As of Jul 22
 +0.52 / +0.80%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 13 analysts offering 12-month price forecasts for Alnylam Pharmaceuticals Inc have a median target of 115.00, with a high estimate of 180.00 and a low estimate of 63.00. The median estimate represents a +75.60% increase from the last price of 65.49.

Analyst Recommendations

The current consensus among 14 polled investment analysts is to Buy stock in Alnylam Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -3.14%
Growthannually -44.42%


Growthquarterly 8.62%
Growthannually 6.39%
Key to the earnings and sales forecast charts.